WEDNESDAY, Sept. 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.

"America’s opioid crisis is not over. We must stay vigilant to address this longstanding problem in new ways. Physicians need more alternatives to opioid medications for patients suffering from chronic pain," FDA Commissioner Marty Makary, M.D., M.P.H., said in a statement. "FDA can help by providing clear guidance like this, which makes regulatory pathways more predictable for innovators and drug developers, enabling effective, lower-risk therapies to quickly reach the millions of Americans living with chronic pain."

According to the FDA, opioids are commonly prescribed t

See Full Page